Clinical Trials: Developmental Therapeutics Clinic

The mission of the Developmental Therapeutics Clinic (DTC) at Memorial Sloan Kettering Cancer Center is to rapidly integrate cancer biology, novel therapeutic agents, and efficient trial design in order to improve the outcomes of cancer patients everywhere.  The DTC cares for patients with cancer who are being treated on phase I and other early-phase clinical trials of novel targeted agents. The members of the DTC research team work closely with the Center for Molecular Oncology to use the techniques of molecular biology to identify specific proteins, genes, or other molecules that influence the growth of each person's cancer, with the goal of selecting the most promising therapies for individual patients.

Patients are referred to the DTC by their medical oncologist at Memorial Sloan Kettering. If you decide to participate in an early-phase clinical trial within the DTC, the clinic's physicians and nurses will care for you during the time you are participating in the study. Once your participation is complete, you will return to your regular medical oncologist for ongoing care.

If you commit to being in an early-phase clinical trial in the DTC, please understand that your participation requires very specific appointment schedules. There may be times when you are asked to stay close to Memorial Sloan Kettering. Some appointments cannot be changed or delayed. Please check with the clinical trial staff before scheduling any vacations or other time away. We will help you coordinate your plans.

Clinic Location and Hours

The DTC is located in the Rockefeller Outpatient Pavilion at 160 East 53rd Street (at Third Avenue). Office hours are 8:00 AM to 5:00 PM, Monday to Friday. Our patients receive treatment in a specialized unit called the Developmental Treatment Unit, which is located immediately adjacent to the DTC on the fourth floor.

Contacting Us

  • The DTC can be reached by phone at 646-888-4226 or by fax at 646-888-4264.
  • Please do not leave urgent messages on the voice messaging system outside of the office hours of 8:00 AM and 5:00 PM. After hours, call 212-639-7900 and ask to speak with the solid tumor fellow on call.
  • In an emergency, call 911 or visit the nearest emergency room.
  • The MSK patient portal can be used to check your appointments and test results, and to send non-urgent e-mails to the DTC nurses.  Instead of sending messages to a specific doctor's office, there is a special link to the DTC healthcare team.  Please speak with the clinic staff if you need information on how to register for or access the patient portal.

Our Team

Patients will receive care from physicians and nurses of the DTC.  

Nursing Team

Jennifer L. Winkelmann, RN
Katherine E. Kargus, RN
Megan A. Stasi, RN


Pictured: Alexander Drilon
Alexander Drilon
Matthew G. Fury, MD, PhD -- Director, Inpatient Medical Oncology Service for Head and Neck Cancer, Melanoma, and Sarcoma
Matthew G. Fury
Director, Inpatient Medical Oncology Service for Head and Neck Cancer, Melanoma, and Sarcoma
John F. Gerecitano, MD, PhD
John F. Gerecitano
Clinical Director of Lymphoma Outpatient Services
Pictured: Mrinal M. Gounder, MD
Mrinal M. Gounder
Pictured: James Harding
James J. Harding
Pictured: David Hyman
David Hyman
Pictured: David Solit -- Geoffrey Beene Chair; Director, Center for Molecular Oncology
David B. Solit
Geoffrey Beene Chair; Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Pictured: Anna Varghese
Anna M. Varghese
Pictured: Martin H. Voss
Martin H. Voss